Oramed Pharmaceuticals Inc. (TLV:ORMP)

Oramed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Aug 31, 2021
Cash & Equivalents	15.8	54.42	9.06	40.46	27.46	77.25
Short-Term Investments	82.14	87.51	152.99	115.26	118.82	16.9
Cash & Short-Term Investments	97.94	141.93	162.05	155.72	146.28	94.14
Cash Growth	-35.88%	-12.41%	4.06%	6.45%	55.39%	-
Prepaid Expenses	0.48	1.29	0.54	1.39	1.66	1.2
Total Current Assets	99.03	143.22	162.58	157.11	147.94	95.34
Property, Plant & Equipment	1.53	1.11	1.57	1.8	0.89	0.93
Long-Term Investments	56.61	10.91	56.37	2.7	3.88	6.69
Other Long-Term Assets	1.99	0.03	0.03	0.03	25.12	25.04
Total Assets	161.68	155.28	220.55	161.64	177.82	128
Accounts Payable	0.72	0.79	0.55	2.18	1.69	2.61
Accrued Expenses	1.13	1.48	1.38	1.97	2.31	1.2
Short-Term Debt	-	-	51.01	-	-	-
Current Portion of Leases	0.26	0.22	0.27	0.25	0.13	0.13
Current Income Taxes Payable	0.34	3.2	-	-	-	-
Current Unearned Revenue	1.24	-	-	1.34	2.7	2.7
Other Current Liabilities	-	-	-	0.01	0.53	0.04
Total Current Liabilities	3.69	5.69	53.21	5.75	7.37	6.68
Long-Term Leases	0.65	0.16	0.34	0.65	0.37	0.4
Long-Term Unearned Revenue	3.72	4	4	4	3.34	4.24
Other Long-Term Liabilities	-	0.06	0.07	0.07	0.11	0.14
Total Liabilities	8.1	9.93	57.66	10.49	11.21	11.48
Common Stock	0.49	0.48	0.49	0.48	0.46	0.42
Additional Paid-In Capital	325.01	322.4	320.89	314.42	292.51	230.2
Retained Earnings	-170.97	-176.62	-157.56	-163.08	-126.52	-114.85
Total Common Equity	154.53	146.27	163.82	151.81	166.45	115.77
Minority Interest	-0.95	-0.92	-0.93	-0.66	0.16	0.74
Shareholders' Equity	153.58	145.35	162.89	151.16	166.61	116.52
Total Liabilities & Equity	161.68	155.28	220.55	161.64	177.82	128
Total Debt	0.91	0.37	51.62	0.89	0.5	0.53
Net Cash (Debt)	97.03	141.56	112.23	154.83	149.66	100.3
Net Cash Growth	-37.24%	26.13%	-27.51%	3.45%	49.21%	-
Net Cash Per Share	2.36	3.47	2.77	3.97	4.03	3.52
Filing Date Shares Outstanding	41	40.85	40.52	39.78	38.56	38.09
Total Common Shares Outstanding	40.85	39.92	40.34	39.56	38.16	35.29
Working Capital	95.33	137.54	109.37	151.36	140.57	88.66
Book Value Per Share	3.78	3.66	4.06	3.84	4.36	3.28
Tangible Book Value	154.53	146.27	163.82	151.81	166.45	115.77
Tangible Book Value Per Share	3.78	3.66	4.06	3.84	4.36	3.28

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.